| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $915.0M | -41.6% | -33.6% |
| Cost of Revenue | $849.0M | -41.0% | -33.3% |
| Gross Profit | $66.0M | -48.4% | -37.1% |
| R&D Expense | $19.0M | -9.5% | -36.7% |
| SG&A Expense | $48.0M | +71.4% | +4.3% |
| Operating Income | -$68.0M | -423.1% | -1.5% |
| Pre-tax Income | -$89.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $962.0M | +21.9% | +16.0% |
| Short-term Investments | $0 | — | -100.0% |
| Current Assets | $2.59B | -7.5% | -20.7% |
| Total Assets | $2.70B | -7.1% | -20.8% |
| Current Liabilities | $914.0M | +42.1% | +26.8% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $979.0M | — | — |
| Capital Expenditures | $9.0M | — | — |
| Investing Cash Flow | -$9.0M | — | — |
| Financing Cash Flow | -$281.0M | — | — |
| Free Cash Flow | $970.0M | — | — |
| -206.9% |
| -14.1% |
| Income Tax | $1.0M | +400.0% | — |
| Net Income | -$90.0M | -210.3% | -15.4% |
| EPS (Basic) | -$0.12 | -200.0% | -9.1% |
| EPS (Diluted) | -$0.12 | -200.0% | -9.1% |
| $1.89B |
| -17.0% |
| -27.6% |
| Stockholders' Equity | $811.0M | +28.5% | +1.2% |